Olaparib
Drug Details
- Description
- Olaparib is a PARP inhibitor used to treat certain types of ovarian, breast, fallopian tube, and peritoneal cancers. It works by preventing cancer cells from repairing their DNA, leading to cell death.
- Alternative Names
- Olaparib
- Key Genes
- BRCA1, BRCA2.
- Drug Use
- Olaparib is used to treat certain types of cancers, including ovarian, breast, pancreatic, and prostate cancers, particularly those with BRCA1 or BRCA2 mutations. It works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which helps repair damaged DNA in cells.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report